Literature DB >> 19371211

Central retinal vein occlusion secondary to clomiphene treatment in a male carrier of factor V Leiden.

Marianna Politou, Argyri Gialeraki, Efrossyni Merkouri, Anthi Travlou, Stefanos Baltatzis.   

Abstract

We report a case of a 35-year-old previously healthy man treated with clomiphene for infertility, who presented with blurred vision in his left eye due to ocular vein occlusion as documented by fluorescein angiography. The patient was heterozygous for the factor V Leiden (FV Leiden) mutation and for the 1298 A-C polymorphism of the methylene-tetrahydrofolate reductase (MTHFR) gene. He was treated with clopidogrel and is now free of symptoms. Because congenital thrombophilia is a moderate risk factor for central retinal vein occlusion and the administration of clomiphene may trigger this process, we recommend screening of young patients for FV Leiden before clomiphene treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371211     DOI: 10.1089/gtmb.2008.0104

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  4 in total

1.  Intracranial venous thrombosis in a man taking clomiphene citrate.

Authors:  M Zahid; A Arshad; A Zafar; D Al-Mohannadi
Journal:  BMJ Case Rep       Date:  2016-11-10

Review 2.  Diagnosis and Management of Anabolic Androgenic Steroid Use.

Authors:  Bradley D Anawalt
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

3.  Pulmonary Embolism as a Rare Complication of Clomiphene Therapy: A Case Report and Literature Review.

Authors:  Vinod Solipuram; Kishor Pokharel; Temple Ihedinmah
Journal:  Case Rep Endocrinol       Date:  2021-09-07

4.  A young woman with sudden visual field shimmering: A case report.

Authors:  Zahra Farzinvash
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.